SOLID TUMOR, ADULT
Clinical trials for SOLID TUMOR, ADULT explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR, ADULT trials appear
Sign up with your email to follow new studies for SOLID TUMOR, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of experimental cancer drug halted
Disease control TerminatedThis early-stage study aimed to find a safe dose of a new drug called BGB-24714 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers tested the drug by itself and combined with chemotherapy or radiation to see how well patients toler…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Virus therapy tested to fight tough cancers
Disease control TerminatedThis early-stage study tested the safety of a new treatment called CF33-CD19, a modified virus designed to attack cancer cells. It was given alone or combined with another immunotherapy drug (blinatumomab) to adults with advanced solid tumors that had stopped responding to at lea…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Cancer-Fighting virus tested in patients with advanced tumors
Disease control TerminatedThis early-stage study tested the safety of an experimental treatment called VAXINIA, which is a modified virus designed to infect and kill cancer cells. It was given to 66 adults with advanced solid tumors that had spread and stopped responding to other treatments. The virus was…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Imugene Limited • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New pill tested as potential lifeline for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new oral drug called NKT3447 in adults with advanced solid tumors that had progressed despite standard treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was later terminated and focused on specif…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New oral cancer pill tested in patients who have run out of options
Disease control TerminatedThis early-stage study tested a new oral medication called IK-595 in adults with advanced solid tumors that have specific genetic changes (RAS or RAF mutations) and no remaining standard treatment options. The main goals were to find a safe dose, see how the body processes the dr…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New gene therapy trial aims to turn immune system against cancer
Disease control TerminatedThis early-stage study is testing a new gene therapy called GEN2 in adults with advanced solid tumors that have stopped responding to standard treatments. The therapy aims to activate the patient's own immune system to recognize and attack their cancer. Researchers will test diff…
Matched conditions: SOLID TUMOR, ADULT
Phase: PHASE1 • Sponsor: GenVivo, Inc. • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC